Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Webcast


Genedrive Share Price (GDR)



Share Price Information for Genedrive (GDR)


Share Price: 37.50Bid: 35.00Ask: 40.00Change: 0.00 (0.00%)No Movement on Genedrive
Spread: 5.00Spread as %: 14.29%Open: 37.50High: 37.50Low: 37.50Yesterday’s Close: 37.50

Genedrive Plc Ord 1.5P

Genedrive is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
37.50
Share Price SpacerBid
35.00
Share Price SpacerAsk
40.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
4,446
Share Price SpacerOpen
37.50
Share Price SpacerHigh
37.50
Share Price SpacerLow
37.50
Share Price SpacerClose
37.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 18.69m £7.01m 1,000

52 Week High 42.50 52 Week High Date 11-AUG-2017
52 Week Low 27.50 52 Week Low Date 16-JAN-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
2 4,446 0 -1.075 -34.90 0.00 0.00


London South East Users info for Genedrive


Users who watch GDR also watch: Redcentric, Accesso Tech, Costain, Ent. One Di, Xlmedia, Next Fifteen, Redde, Renew Holdings

Users who hold GDR also hold: Dixons Carpho, Barclays


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

25-May-18
08:31:41
37.00
1,081
Sell* 
35.00
40.00
399.97
Trade Type:
Ordinary

25-May-18
08:25:24
37.00
3,365
Sell* 
35.00
40.00
1,245
Trade Type:
Ordinary

24-May-18
14:28:46
35.00
4,000
Sell* 
35.00
40.00
1,400
Trade Type:
Ordinary




View more Genedrive trades >>

Directors Deals for Genedrive (GDR)
Trade DateActionNotifierPriceCurrencyAmountHolding
There is currently no Directors Deals information for Genedrive
View more Genedrive directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Sun 06:57riddlerCtw38.50No Opinion
Thanks mate
Sat 10:30Ctw2014Shareholders38.50No Opinion
As discussed. Not up to date. The Pru now have over 13% and Amati were up to over 4% as per RNS of 10/5/18, which is not showing here for some reason.
Sat 08:09riddlerHoldings RNS38.50No Opinion
15 May '18TroytoTiberDelivery38.50Strong Buy
Management continue to deliver everything that they say they will. Credibility going up around this team in my view. First commercial sales of tb tests in h2 2019 as stated by management then becomes very interesting if we assume that they continue to only make statements about things they feel confident they can deliver. Wider market clearly not willing to price that 18 month prospect in yet, not even one based only on hcv. Once repeatable sales are demonstrated and growing the prospect of… Read More
15 May '18Ctw2014?1.9m38.50No Opinion
Yep, it’s been flagged for a while and looks a decent deal to me. Disposal of a non core part of the business generating additional cash for the diagnostics business going forward. Reasonable lock in provisions for Dr Booth’s shareholding. First commercial revenues for the HCV kit booked in March 2018. If sales go well we should be set fair.
15 May '18riddler?1.9mln38.50No Opinion
Disposal
After hours RNS

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Genedrive (GDR) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.